Bella Capsules — Class I drug recall D-0593-2018
Terminated recall by Bella All Natural, reported 2018-03-14, distributed in CA. Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutrami
| Recall number | D-0593-2018 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Bella All Natural, Los Angeles, CA, United States |
| Recall initiated | 2018-02-14 |
| Classified | 2018-03-13 |
| Reported by FDA | 2018-03-14 |
| Terminated | 2019-01-28 |
| Distributed | CA |
| Quantity | 32 bottles |
| Reason classes | undeclared allergen, unapproved product |
| Expiration dates | 2019-10-14 |
Product
Bella Capsules, 600mg, 30-count bottles, Manufactured for: Bella All Natural 304 E 11th Street, Los Angeles, CA 90015
Reason for recall
Marketed Without An Approved NDA/ANDA: This product contains undeclared sibutramine. The presence of sibutramine, a previously approved controlled substance that was withdrawn from the U.S. market in October 2010 due to safety concerns, in this tainted product renders it an unapproved drug for which safety and efficacy have not been established and therefore subject to recall.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0593-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.